The global interventional radiology market size reached USD 28.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 47.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.95% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 28.1 Billion |
Market Forecast in 2033
|
USD 47.3 Billion |
Market Growth Rate 2025-2033 | 5.95% |
Interventional radiology (IR) refers to several techniques that rely on radiological images guidance, such as X-ray fluoroscopy, ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), to diagnose and cure diseases. It helps make small incisions in the abdomen using needles and catheters. It is widely utilized for repairing blood vessels, treating weak arteries, dissolving blood clots, blocking blood flow to cancer cells, and reducing nerve pain. In addition, as it is less expensive, risky, and painful as compared with traditional surgeries, IR finds extensive application in oncology, cardiology, urology and nephrology, and gastroenterology across the globe.
The growing prevalence of chronic diseases on account of the increasing consumption of fast food and the sedentary lifestyle of individuals represents one of the key factors driving the market. Moreover, rising minimally invasive (MI) procedures as they are cost-effective and require lesser hospital stays, along with the augmenting healthcare expenditure, is propelling the growth of the market. In addition, technological advancements in imaging technologies, which provide real-time images to radiologists for showing a comprehensive view of internal organs, are stimulating the market growth. Besides this, there is an increase in the utilization of augmented reality (AR) technology that offers the ability to move scopes and devices inside the body and interact with the surroundings. This, coupled with various developments in artificial intelligence (AI) to detect abnormalities and anomalies in medical images, is positively influencing the market. Additionally, the expanding application of optical coherence tomography (OCT) and fractional flow reserve (FFR) for stenting patients with multi-vessel coronary artery disease (CAD) is contributing to the growth of the market. Furthermore, governments of several countries are generating awareness about the effectiveness of IR techniques for the diagnosis of cancer, which is bolstering the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global interventional radiology market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on product, procedures, application and end use.
Breakup by Product:
Breakup by Procedures:
Breakup by Application:
Breakup by End Use:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, Cook Group Incorporated, Esaote SpA, Fujifilm Holdings Corporation, General Electric Company, Hologic Inc, Koninklijke Philips N.V., Medtronic plc, Nipro Corporation, Shimadzu Corporation, Siemens Aktiengesellschaft and Teleflex Incorporated.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Product, Procedures, Application, End Use, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Boston Scientific Corporation, Cook Group Incorporated, Esaote SpA, Fujifilm Holdings Corporation, General Electric Company, Hologic Inc, Koninklijke Philips N.V., Medtronic plc, Nipro Corporation, Shimadzu Corporation, Siemens Aktiengesellschaft and Teleflex Incorporated. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global interventional radiology market was valued at USD 28.1 Billion in 2024.
We expect the global interventional radiology market to exhibit a CAGR of 5.95% during 2025-2033.
The rising prevalence of several chronic diseases, along with the increasing utilization of interventional radiology for conducting Minimally Invasive (MI) procedures to improve patient care quality, is primarily driving the global interventional radiology market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing demand for interventional radiology in chest CT scan procedures as they have high sensitivity for diagnosis of the COVID-19 infection.
Based on the product, the global interventional radiology market can be segmented into Magnetic Resonance Imaging (MRI), ultrasound imaging systems, Computed Tomography (CT) scanners, angiography systems, fluoroscopy systems, biopsy devices, and others. Currently, Magnetic Resonance Imaging (MRI) holds the majority of the total market share.
Based on the procedures, the global interventional radiology market has been divided into angiography, angioplasty, embolization, vertebroplasty, thrombolysis, nephrostomy placement, and others. Among these, angiography currently exhibits a clear dominance in the market.
Based on the end use, the global interventional radiology market can be categorized into hospitals, clinics, and ambulatory surgical centers. Currently, hospitals account for the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global interventional radiology market include Boston Scientific Corporation, Cook Group Incorporated, Esaote SpA, Fujifilm Holdings Corporation, General Electric Company, Hologic Inc, Koninklijke Philips N.V., Medtronic plc, Nipro Corporation, Shimadzu Corporation, Siemens Aktiengesellschaft, and Teleflex Incorporated.